These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 12374571

  • 1. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M, Patarroyo-White S, Qian X, Arnold KS, Rohrer L, Balestra ME, Innerarity TL.
    Biochem J; 2003 Jan 15; 369(Pt 2):255-62. PubMed ID: 12374571
    [Abstract] [Full Text] [Related]

  • 2. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X, Balestra ME, Yamanaka S, Borén J, Lee I, Innerarity TL.
    Arterioscler Thromb Vasc Biol; 1998 Jun 15; 18(6):1013-20. PubMed ID: 9633945
    [Abstract] [Full Text] [Related]

  • 3. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD, Rouy D, Navaratnam N, Scott J, Rubin EM.
    Hum Gene Ther; 1996 Jan 15; 7(1):39-49. PubMed ID: 8825867
    [Abstract] [Full Text] [Related]

  • 4. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
    Yamanaka S, Poksay KS, Driscoll DM, Innerarity TL.
    J Biol Chem; 1996 May 10; 271(19):11506-10. PubMed ID: 8626710
    [Abstract] [Full Text] [Related]

  • 5. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
    Greeve J, Jona VK, Chowdhury NR, Horwitz MS, Chowdhury JR.
    J Lipid Res; 1996 Sep 10; 37(9):2001-17. PubMed ID: 8895066
    [Abstract] [Full Text] [Related]

  • 6. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
    Hersberger M, Innerarity TL.
    J Biol Chem; 1998 Apr 17; 273(16):9435-42. PubMed ID: 9545269
    [Abstract] [Full Text] [Related]

  • 7. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K, Kobayashi K, Sullivan M, Martinez J, Teng BB, Ishimura-Oka K, Chan L.
    J Biol Chem; 1997 Jan 17; 272(3):1456-60. PubMed ID: 8999814
    [Abstract] [Full Text] [Related]

  • 8. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, Chan L.
    J Biol Chem; 1996 Oct 18; 271(42):25981-8. PubMed ID: 8824235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF, Van Mater D, Sowden MP, Smith HC.
    Exp Cell Res; 1999 Oct 10; 252(1):154-64. PubMed ID: 10502408
    [Abstract] [Full Text] [Related]

  • 12. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
    Davidson NO, Shelness GS.
    Annu Rev Nutr; 2000 Oct 10; 20():169-93. PubMed ID: 10940331
    [Abstract] [Full Text] [Related]

  • 13. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J, Axelos D, Welker S, Schipper M, Greten H.
    Arterioscler Thromb Vasc Biol; 1998 Jul 10; 18(7):1079-92. PubMed ID: 9672068
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP, Eagleton MJ, Smith HC.
    Nucleic Acids Res; 1998 Apr 01; 26(7):1644-52. PubMed ID: 9512534
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein B: from editosome to proteasome.
    Chan L, Chang BH, Liao W, Oka K, Lau PP.
    Recent Prog Horm Res; 2000 Apr 01; 55():93-125; discussion 126. PubMed ID: 11036935
    [Abstract] [Full Text] [Related]

  • 16. Recapture of hepatic apolipoprotein B mRNA editing may be a promising strategy to relieve nephrotic dyslipidemia.
    Hu P, Lu L, Hu B, Qin YH.
    Med Hypotheses; 2010 Dec 01; 75(6):561-3. PubMed ID: 20705399
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.